1st Quarter - Amendment
EMPIRE CONSULTING GROUP for GILEAD SCIENCES INC.
Client
Income
$50,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report | Apr 19, 2018 | $50,000 | Replaced |
| 1st Quarter - Amendment (this page) | Apr 20, 2018 | $50,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Prescription drug costs; 340B Drug Pricing Program; Consolidated Appropriations Act, 2018 (provisions related to prescription drugs); Support HIV/AIDs and viral hepatitis research, screening, testing, treatment and coverage and reimbursement for pharmaceuticals.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHAKA BURGESS | — |
| MIKE MCKAY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.